Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Dose-Response and Normal Tissue Complication Probabilities after Proton Therapy for Choroidal Melanoma

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Uveitis in Juvenile Idiopathic Arthritis: 18-Year Outcome in the Population-based Nordic Cohort Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Peripapillary Ovoid Hyperreflectivity in Optic Disc Edema and Pseudopapilledema

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Adrenal Suppression in Infants Treated with Topical Ocular Glucocorticoids

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. COMPARATIVE EFFECTIVENESS OF PROTON BEAM VERSUS PHOTODYNAMIC THERAPY TO SPARE THE VISION IN CIRCUMSCRIBED CHOROIDAL HEMANGIOMA

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Measuring aniseikonia tolerance range for stereoacuity - a tool for the refractive surgeon

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Monocular and binocular end-points after epiretinal membrane surgery and their correlation to patient-reported outcomes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Tumour control probability after Ruthenium-106 brachytherapy for choroidal melanomas

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

PURPOSE: Normal tissue complication probability (NTCP) models could aid the understanding of dose dependence of radiation-induced toxicities after eye-preserving radiotherapy of choroidal melanomas. We performed NTCP-modeling and established dose-response relationships for visual acuity (VA) deterioration and common late complications after treatments with proton therapy (PT).

DESIGN: Retrospective study from single, large referral center.

PARTICIPANTS: We considered patients from Nice, France, diagnosed with choroidal melanoma and treated primarily with hypofractionated PT (52 Gy physical dose in 4 fractions). Complete VA deterioration information was available for 1020 patients, and complete information on late complications was available for 991 patients.

METHODS: Treatment details, dose-volume histograms (DVHs) for relevant anatomic structures, and patient and tumor characteristics were available from a dedicated ocular database. Least absolute shrinkage and selection operator (LASSO) variable selection was used to identify variables with the strongest impact on each end point, followed by multivariate Cox regressions and logistic regressions to analyze the relationships among dose, clinical characteristics, and clinical outcomes.

MAIN OUTCOME MEASURES: Dose-response relationship for VA deterioration and late complications.

RESULTS: Dose metrics for several structures (i.e., optic disc, macula, retina, globe, lens, ciliary body) correlated with clinical outcome. The near-maximum dose to the macula showed the strongest correlation with VA deterioration. The near-maximum dose to the retina was the only variable with clear impact on the risk of maculopathy, the dose to 20% of the optic disc had the largest impact on optic neuropathy, dose to 20% of cornea had the largest impact on neovascular glaucoma, and dose to 20% of the ciliary body had the largest impact on ocular hypertension. The volume of the ciliary body receiving 26 Gy was the only variable associated with the risk of cataract, and the volume of retina receiving 52 Gy was associated with the risk of retinal detachment. Optic disc-to-tumor distance was the only variable associated with dry eye syndrome in the absence of DVH for the lachrymal gland.

CONCLUSIONS: VA deterioration and specific late complications demonstrated dependence on dose delivered to normal structures in the eye after PT for choroidal melanoma. VA deterioration depended on dose to a range of structures, whereas more specific complications were related to dose metrics for specific structures.

OriginalsprogEngelsk
TidsskriftOphthalmology
Vol/bind128
Udgave nummer1
Sider (fra-til)152-161
Antal sider10
ISSN0161-6420
DOI
StatusUdgivet - jan. 2021

Bibliografisk note

Copyright © 2020 American Academy of Ophthalmology. All rights reserved.

ID: 62034118